Combination treatment strategies in early rheumatoid arthritis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15860511.
- Also identified by PMC identifier 1755668.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Combinations of disease modifying antirheumatic drugs (DMARDs) are increasingly being used in patients with early rheumatoid arthritis (RA) when long term results with sequential DMARD monotherapy are disappointing. Combination DMARD therapy may be more effective than monotherapy, and has no additional short term adverse events. The evidence for using combination DMARD therapy is still weak, however, and further trials are needed.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid